Eurocine Vaccines AB8X4 
$0.0014.29%24h
14.29%24h
Global rank
Market cap$147.35K
Change 7d-11.11%
YTD Performance-42.86%
SP500 benchmarkUnderperform
P/E-0.01
P/S0
Revenue$0
Earnings-$1.78M
Dividend yield-
Main Sector
Healthcare
Category
Eurocine Vaccines AB (8X4) Stock Overview
Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. The company is developing Herpes Simplex Virus type 2 and Chlamydia vaccines. Eurocine Vaccines AB (publ) was incorporated in 1999 and is based in Solna, Sweden.
8X4 Stock Information
Symbol
8X4Address
Nanna Svartz vag 4Solna, 171 65Sweden
Founded
-Trading hours
-Website
https://www.eurocine-vaccines.comCountry
🇸🇪 SwedenPhone Number
46 7 06 34 01 71Eurocine Vaccines AB (8X4) Price Chart
-
Value:-
Eurocine Vaccines AB Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $0.0017737179345054654 | N/A |
| Market Cap | $147.35K | N/A |
| Shares Outstanding | 83.07M | 68.24% |
| Employees | 3.00 | N/A |
| Shareholder Equity | 3.21M | -79.39% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -0.01 | N/A |
| P/B Ratio | 0.05 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | -0.5550 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $0 | N/A |
| Earnings | -$1.78M | N/A |
| EPS | -0.2333 | N/A |
| Earnings Yield | -131.51 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $541.12K | N/A |
| Cash on Hand | $101.25K | N/A |
| Debt to Equity | 0.0715 | 256.95% |
| Current Ratio | $2.36 | -59.69% |
